Abstract β-Thalassemia is one of the most common monogenetic diseases worldwide, with a
particularly high prevalence in the Middle East region. As such, we have developed long …

Problems and Approaches for Blood Transfusion in the Developing Countries - Hematology/Oncology
Clinics Skip to Main Content Advertisement Hematology/Oncology Clinics Log in Register Log …

Thalassemia is a common inherited monogenic disease. It is characterized by chronic
hemolysis, ineffective erythropoiesis (IE) and iron overload. Despite advances in transfusion …

Objective This study focused on the efficacy and safety of thalidomide for patients with β-
thalassemia in a multicenter trial. Methods Patients with non-transfusion-dependent …

Sickle cell disease (SCD) and β-thalassemia are among the most common inherited
diseases, affecting millions of persons globally. It is estimated that 5–7% of the world's …

Background Non‐transfusion dependent beta thalassaemia is a subset of inherited
haemoglobin disorders characterised by reduced production of the beta globin chain of the …

To investigate the efficacy and safety of thalidomide in patients with thalassemia intermedia
(TI). Patients with a confirmed diagnosis of TI who met the trial criteria and signed consent …

Matched-related bone marrow transplantation (BMT) may cure> 80% of low-risk children
with severe thalassemia (ST). Very long-term follow-up studies have shown how the …

Objective: To investigate the effect of thalidomide in patients with thalassemia intermedia.
Methods: We observed the effect of thalidomide in seven patients with thalassemia …

Background Hydroxyurea (HU) has been widely used in clinical practice to manage patients
with non-transfusion dependent thalassemia (NTDT). Few data are available about the …